SC

Samarveer Chawla

Active Director Additional Director DIN 11124569
DIN 11124569 First appointment May 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Samarveer Chawla

Data last updated:

Samarveer Chawla is an Additional Director at Epick Drugs Private Limited (since 2025). The company operates in Paper.

DIN 11124569
Primary Designation Additional Director
Industry Paper
First Appointment 26 May 2025
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Epick Drugs Private Limited U21009HR2024PTC121657
Additional Director26 May 20252024Active

Board colleagues of Samarveer Chawla

Directorship timeline

Open interactive timeline →
Epick Drugs Private Limited
Premium access

Shareholding and investment profile for Samarveer Chawla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samarveer Chawla

Samarveer Chawla currently holds 1 directorship: Epick Drugs Private Limited (Additional Director, since 26 May 2025).

Samarveer Chawla was first appointed on 26 May 2025 as Additional Director at Epick Drugs Private Limited.

The current boards of Samarveer Chawla's companies include Aastha (Epick Drugs Private Limited), Lakshay Goyal (Epick Drugs Private Limited), Madhu Goyal (Epick Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available